Rabbit AGPAT2 (D8W9B) Monoclonal Antibody

Rabbit AGPAT2 (D8W9B) Monoclonal Antibody

Cat. No.: DAB-0011699

Size: 20 µL Size: 100 µL Size: Customer Size
Product Information
Clonality Monoclonal
Isotype IgG
Host Species Rabbit
Reactivity Human
Applications WB, IP
Product Description Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly235 of human AGPAT2 protein.
Format Liquid
Purity Affinity purity
Target Information
Target Name AGPAT2
UniProt No. O15120
Gene ID 10555
Gene Description The 1-acylglycerol-3-phosphate-O-acyltransferase 2 enzyme catalyzes the acylation of lysophosphatidic acid into phosphatidic acid, which is a precursor for the synthesis of triacylglycerol and phospholipid. AGPAT2 is highly expressed in adipose tissues, liver, and skeletal muscle. The induced knockdown of AGPAT2 expression results in decreased expression of adipogenic proteins and delayed expression of adipogenic marker proteins, suggesting that AGPAT2 plays an important role in adipocyte growth and differentiation. Mutations in the corresponding AGPAT2 gene cause autosomal recessive congenital generalized lipodystrophy type 1, also described as Berardinelli-Seip syndrome. Patients with CGL1 are born without detectable white adipose tissue and tend to develop severe insulin resistance, hypertriglyceridemia, and type 2 diabetes during childhood.
Shipping & Storage
Shipping Shipped at 4 °C.
Storage Instructions Store at –20 °C. Do not aliquot the antibody.
Storage Buffer Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Products
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top